| First Author | Paris ND | Year | 2015 |
| Journal | Dev Biol | Volume | 407 |
| Issue | 1 | Pages | 40-56 |
| PubMed ID | 26278035 | Mgi Jnum | J:227024 |
| Mgi Id | MGI:5699524 | Doi | 10.1016/j.ydbio.2015.08.009 |
| Citation | Paris ND, et al. (2015) Wt1 and beta-catenin cooperatively regulate diaphragm development in the mouse. Dev Biol 407(1):40-56 |
| abstractText | The developing diaphragm consists of various differentiating cell types, many of which are not well characterized during organogenesis. One important but incompletely understood tissue, the diaphragmatic mesothelium, is distinctively present from early stages of development. Congenital Diaphragmatic Hernia (CDH) occurs in humans when diaphragm tissue is lost during development, resulting in high morbidity and mortality postnatally. We utilized a Wilms Tumor 1 (Wt1) mutant mouse model to investigate the involvement of the mesothelium in normal diaphragm signaling and development. Additionally, we developed and characterized a Wt1(CreERT2)-driven beta-catenin loss-of-function model of CDH after finding that canonical Wnt signaling and beta-catenin are reduced in Wt1 mutant mesothelium. Mice with beta-catenin loss or constitutive activation induced in the Wt1 lineage are only affected when tamoxifen injection occurs between E10.5 and E11.5, revealing a critical time-frame for Wt1/ beta-catenin activity. Conditional beta-catenin loss phenocopies the Wt1 mutant diaphragm defect, while constitutive activation of beta-catenin on the Wt1 mutant background is sufficient to close the diaphragm defect. Proliferation and apoptosis are affected, but primarily these genetic manipulations appear to lead to a change in normal diaphragm differentiation. Our data suggest a fundamental role for mesothelial signaling in proper formation of the diaphragm. |
